[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336946-105":59,"doc-detail-336946-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","prescription-opioid-use-before-and-after-diagnosis-of-cancer-among-older-cancer-survivors-with-non-cancer-chronic-pain-conditions-ncpcs-an-application-of-group-based-trajectory-modeling-gbtm","Prescription Opioid Use before and after Diagnosis of Cancer Among Older Cancer Survivors With Non-Cancer Chronic Pain Conditions (NCPCs) - An Application of Group-Based Trajectory Modeling (GBTM)","","Prescription opioids play a key role in managing pain for adults with chronic conditions, yet sustained use can increase risks of harm such as abuse and overdose. This retrospective cohort study uses linked SEER-Medicare data (2007–2015; N=35,071) to model opioid-use trajectories among older cancer survivors with non-cancer chronic pain conditions. Group-Based Trajectory Modeling identifies distinct patterns across pre-diagnosis, acute treatment, and post-treatment periods, and multivariable multinomial models assess associated factors.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prescription-opioid-use-before-and-after-diagnosis-of-cancer-among-older-cancer-survivors-with-non-cancer-chronic-pain-conditions-ncpcs-an-application-of-group-based-trajectory-modeling-gbtm/336946/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prescription-opioid-use-before-and-after-diagnosis-of-cancer-among-older-cancer-survivors-with-non-cancer-chronic-pain-conditions-ncpcs-an-application-of-group-based-trajectory-modeling-gbtm/336946.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of this study?","Question",{"text":113,"@type":114},"To examine how prescription opioid use changes over time and to identify factors associated with different opioid-use trajectories among older cancer survivors with non-cancer chronic pain conditions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were opioid-use trajectories identified?",{"text":118,"@type":114},"Using Group-Based Trajectory Modeling (GBTM) based on every 90-day prescription opioid use across pre-cancer diagnosis, acute cancer treatment, and post-cancer treatment periods.",{"name":120,"@type":111,"acceptedAnswer":121},"What opioid-use patterns were found?",{"text":122,"@type":114},"Four trajectories were identified: increase-decrease use, short-term use after cancer diagnosis, low-use, and persistent use, with persistent use affecting about 12.3% of individuals.",{"name":124,"@type":111,"acceptedAnswer":125},"Which factors were associated with persistent opioid use?",{"text":126,"@type":114},"Factors linked to persistent use included social determinants such as Non-Hispanic Black status and rural residence, comorbid anxiety, and certain medication use (NSAIDs). Higher fragmented care index and greater Medicare Advantage penetration were associated with a lower likelihood of persistent use.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},336946,1790179562,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":36,"preview_page_count":19,"preview_urls":150},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","| Prescription Opioid Use before and after Diagnosis of Cancer Among Older Cancer Survivors With Non-Cancer Chronic Pain Conditions (NCPCs): An Application of Group-Based Trajectory Modeling (GBTM) | Cancer Control Volume 31: 1–16\u003Cbr>© The Author(s) 2024\u003Cbr>Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)\u003Cbr>[DOI: 10.1177/10732748241290769](DOI: 10.1177/10732748241290769)[ ](DOI: 10.1177/10732748241290769)[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Rudi Safarudin 1,2,3 􀀁, Traci LeMasters2,4 􀀁, Salman Khan5 􀀁, and Usha Sambamoorthi2,6 􀀁\u003Cbr>Abstract\u003Cbr>Background: Prescription opioids are essential in managing pain among adults with chronic pain conditions. However, persistent use over time can lead to negative health consequences. Identifying individuals with persistent use over time and their characteristics can inform clinical decision-making and aid in reducing the risk of abuse and overdose deaths.\u003Cbr>Objective: This study aims to examine trajectories of prescription opioid use over time and factors associated with these trajectories among older cancer survivors with any non-cancer pain conditions (NCPC).\u003Cbr>Methods: We conducted a retrospective cohort study design with longitudinal data of older (age at cancer diagnosis ≥67 years) cancer (incident breast, colorectal, and prostate cancers, or non-Hodgkin lymphoma) survivors with any NCPC. Data were derived from the 2007-2015 linked Surveillance, Epidemiology, and End Results (SEER)-Medicare dataset (N = 35,071). GroupBased Trajectory Modeling (GBTM) was used to identify homogeneous subgroups (distinct trajectories) of individuals based onevery 90-day prescription opioid use during pre-cancer diagnosis (t 1 -t4), acute cancer treatment (t5-t8), and post-cancer treatment (t9-t 12) periods. Biological factors, social determinants of health (SDoH), physical and mental health, medication use, health care use, and external factors associated with a trajectory membership were analyzed with multivariable multinomial logistic regressions.\u003Cbr>Results: Four distinct trajectories of opioid use were identiﬁed: (1) increase-decrease use (6.1%); (2) short-term use after cancer diagnosis (40.6%); (3) low-use (41.0%); and (4) persistent use (12.3%). In the fully-adjusted multinomial logistic regression, the SDoH such as Non-Hispanic Black [adjusted odds ratios (AOR) = 1.69; 95%CI = 1.48, 1.93)] and rural residence (AOR = 1.49; 95%CI = 1.15, 1.94)], comorbid anxiety (AOR = 1.33; 95%CI = 1.18, 1.51), and medication use (NSAIDs-AOR = 1.20; 95%CI = 1.10, 1.30) were associated with membership in the persistent use group. Persistent use was less likely among those with higher fragmented care index (AOR = 0.95, 95%CI = 0.93, 0.97) and those living in counties with higher Medicare advantage penetration (AOR = 0.96; 95%CI = 0.95, 0.97) . |  |\n| 1 Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Tadulako University, Palu, Central Sulawesi, Indonesia 2Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, WV, USA 3Prescription Drug Misuse Education and Research (PREMIER) Center, College of Pharmacy, University of Houston, Houston, TX, USA 4OPEN Health, Bethesda, MD, USA\u003Cbr>5Department of Internal Medicine, School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA 6Department of Pharmacotherapy, College of Pharmacy, University of North Texas Health Sciences Center, Fort Worth, TX, USA\u003Cbr>Corresponding Author:\u003Cbr>Rudi Safarudin, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Tadulako University, Jl. Soekarno Hatta Km. 9, Palu, Central Sulawesi, Indonesia, 94148.\u003Cbr>Email: rudi [17safarudin@gmail.com](17safarudin@gmail.com) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativ","cbCaipDRcNpFvDrE","https://ap.wps.com/l/cbCaipDRcNpFvDrE","pdf",781835,16,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusions\n## Plain Language Summary","[{\"question\":\"What was the purpose of this study?\",\"answer\":\"To examine how prescription opioid use changes over time and to identify factors associated with different opioid-use trajectories among older cancer survivors with non-cancer chronic pain conditions.\"},{\"question\":\"How were opioid-use trajectories identified?\",\"answer\":\"Using Group-Based Trajectory Modeling (GBTM) based on every 90-day prescription opioid use across pre-cancer diagnosis, acute cancer treatment, and post-cancer treatment periods.\"},{\"question\":\"What opioid-use patterns were found?\",\"answer\":\"Four trajectories were identified: increase-decrease use, short-term use after cancer diagnosis, low-use, and persistent use, with persistent use affecting about 12.3% of individuals.\"},{\"question\":\"Which factors were associated with persistent opioid use?\",\"answer\":\"Factors linked to persistent use included social determinants such as Non-Hispanic Black status and rural residence, comorbid anxiety, and certain medication use (NSAIDs). Higher fragmented care index and greater Medicare Advantage penetration were associated with a lower likelihood of persistent use.\"}]","Prescription Opioid Use before and after Diagnosis of Cancer Among Older Cancer Survivors With Non-Cancer Chronic Pain Conditions (NCPCs) - An Application of Group-Based Trajectory Modeling (GBTM) | PDF",1790017171,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aae7ae75084b4350b84fd5ba47afd596.webp",983,1272,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c61ed2c90ba1723912345e64fe1d0f65.webp",982,1270,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb97c70c6c4c901d6642951d50b8c608.webp",981,1269,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dafc35123a0604e98a1dbd4a017c30aa.webp",980,1268]